MVK, NLRP3, TNFRSF1A and MEFV gene mutation distributions in childhood autoinflammatory diseases: Experiences in North Anatolia

Engin Altundağ; Ümmet Abur; Ömer Salih Akar; Alişan Yıldıran; Mehmet Halil Çeliksoy; Alberta G. A. Paul; Hatice Mutlu Albayrak; Medine Karadağ Alpaslan; Gönül Oğur

Araştırma Makalesi

Yıl 2023, Cilt: 40 Sayı: 4, 681 - 686, 03.01.2024

Engin Altundağ Ümmet Abur Ömer Salih Akar Alişan Yıldıran Mehmet Halil Çeliksoy Alberta G. A. Paul Hatice Mutlu Albayrak Medine Karadağ Alpaslan Gönül Oğur

Öz

Kaynakça

1. Ozen, S. & Bilginer, Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin Nat. Rev. Rheumatol,2013doi:10.1038/nrrheum.2013.174
2. McDermott MF, Aksentijevich I, Galon J, McDermott EM,Ogunkolade BW, Centola M, et al. Germline variants in the extracellulardomains of the 55 kDa TNF receptor, TNFR1, define afamily of dominantly inherited autoinflammatory syndromes. Cell.1999;97:133–44.
3. Samuels J, Ozen S. Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 2006; 18:108–17.
4. Robartelli A. Autoinflammatory Diseases Immunology Letters 161(2014) 216-230dx.doi.org/10.1016/j.imlet.2013.12.013
5. Baskın E, Saatci U. Familial Mediterranean Fever. Current Rheumatology Reviews,2006; 2:101-108.
6. Hegazy M. T, Fayet A, Nuzollese, Sota J, Ragab G Autoinflammatory diseases and the kidney Immunol Res. 2023, 29. doi: 10.1007/s12026-023-09375-3
7. Federici S, et al.; Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers; Ann Rheum Dis 2015;0:1–7. doi:10.1136/annrheumdis-2014-206580
8. Jesus AA, Fujihira E, Watase M, Terreri MT, Hilario MO, Carneiro-Sampaio M, Len CA, Oliveira SK, Rodrigues MC, Pereira RM, Bica B, Silva NA, Cavalcanti A, Marini R, Sztajnbok F, Quintero MV, Ferriani VP, Moraes-Vasconcelos D, Silva CA, Oliveira JB.Hereditaryautoinflammatory syndromes: a Brazilian multicenter study.JClinImmunol. 2012, 32(5):922-32. doi: 10.1007/s10875-012-9688-x. Epub 2012 May 8.
9. L Federici, C Rittore-Domingo, I Kone´-Paut, C Jorgensen, M Rodie` re, A Le Quellec,I Touitou. A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients; Ann Rheum Dis 2006; 65:1427–1432.
10. A Berdeli, S Nalbantoglu, D Tigli, I Demirel, M Atan, and B Sozeri. Association of novel NLRP3 variants with CAPS phenotype in Turkish patients. Pediatric Rheumatology 2013.
11. Akdeniz S., Periyodik Ateş Sendromlarında TNFRSF1A geninin Öneminin Araştırılması [Yüksek Lisans Tezi] Akdeniz Üniversitesi; 2010

MVK, NLRP3, TNFRSF1A and MEFV gene mutation distributions in childhood autoinflammatory diseases: Experiences in North Anatolia

Yıl 2023, Cilt: 40 Sayı: 4, 681 - 686, 03.01.2024

Engin Altundağ Ümmet Abur Ömer Salih Akar Alişan Yıldıran Mehmet Halil Çeliksoy Alberta G. A. Paul Hatice Mutlu Albayrak Medine Karadağ Alpaslan Gönül Oğur

Öz

Autoinflammatory diseases (AID) are characterised by recurrent fever and inflammation without an apparent infectious etiology and include Familial Mediteranean Fever (FMF), Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS), Hyper-IgD/ Mevalonate Kinase Deficiency Syndrome (HIDS/MKD), Cryopyrin-Associated Periodic Syndromes (CAPS) associated with MEFV, TNFRSF1A, MVK and NLRP3 gene variants. Totally 286 pediatric patients prediagnosed with AID were included in this study. Targeted sequence analysis of MEFV, TNFRSF1A, MVK and NLRP3 genes were performed with Sanger sequencing. Patients were grouped into two categories by the presence of MEFV variant: AIDgroup and MEFV-WTgroup.194 patients fell into AIDgroup and remaining 92 patients were in MEFV-WTgroup. Genetic variants were detected in 69% (135/194) of the patients in first group (AIDgroup). Of these patients, 62 (46%) had MEFV, 41 (30%) had MVK, 20 (15%) had NLRP3, 12 (9%) had TNFRSF1A variants. Pathogenic variants in these genes other than MEFV were detected in 6 (3%) of the 194 patients. Five of them had heterozygous variants in the MVK gene including V377I (four patients) and N205S variants (one patient). Also, in the TNFRSF1A gene N145S variant was detected in only one patient (0.5%). No pathogenic variant was detected in the NLRP3 gene. In second group (MEFV-WTgroup), 3% (3/92) of the patients had pathogenic variants including NLRP3 I313V variant (2 patients) and MVK V377I variant (1 patient). No pathogenic variant was detected in the TNFRSF1A gene. This is the first study to describe the distributions of variants in the MEFV, NLRP3, MVK and TNFRSF1A genes of the pediatric AID population in Central Black Sea region of Turkiye. Our results are consistent with the literature in terms of the variant distribution. However, pathogenic variant rates were lower than the literature data. The variant spectrum was also limited in this study possibly due to a smaller study size.

Anahtar Kelimeler

autoinflammatory, MVK, MEFV, fever

Kaynakça

1. Ozen, S. & Bilginer, Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin Nat. Rev. Rheumatol,2013doi:10.1038/nrrheum.2013.174
2. McDermott MF, Aksentijevich I, Galon J, McDermott EM,Ogunkolade BW, Centola M, et al. Germline variants in the extracellulardomains of the 55 kDa TNF receptor, TNFR1, define afamily of dominantly inherited autoinflammatory syndromes. Cell.1999;97:133–44.
3. Samuels J, Ozen S. Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever. Curr Opin Rheumatol 2006; 18:108–17.
4. Robartelli A. Autoinflammatory Diseases Immunology Letters 161(2014) 216-230dx.doi.org/10.1016/j.imlet.2013.12.013
5. Baskın E, Saatci U. Familial Mediterranean Fever. Current Rheumatology Reviews,2006; 2:101-108.
6. Hegazy M. T, Fayet A, Nuzollese, Sota J, Ragab G Autoinflammatory diseases and the kidney Immunol Res. 2023, 29. doi: 10.1007/s12026-023-09375-3
7. Federici S, et al.; Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers; Ann Rheum Dis 2015;0:1–7. doi:10.1136/annrheumdis-2014-206580
8. Jesus AA, Fujihira E, Watase M, Terreri MT, Hilario MO, Carneiro-Sampaio M, Len CA, Oliveira SK, Rodrigues MC, Pereira RM, Bica B, Silva NA, Cavalcanti A, Marini R, Sztajnbok F, Quintero MV, Ferriani VP, Moraes-Vasconcelos D, Silva CA, Oliveira JB.Hereditaryautoinflammatory syndromes: a Brazilian multicenter study.JClinImmunol. 2012, 32(5):922-32. doi: 10.1007/s10875-012-9688-x. Epub 2012 May 8.
9. L Federici, C Rittore-Domingo, I Kone´-Paut, C Jorgensen, M Rodie` re, A Le Quellec,I Touitou. A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients; Ann Rheum Dis 2006; 65:1427–1432.
10. A Berdeli, S Nalbantoglu, D Tigli, I Demirel, M Atan, and B Sozeri. Association of novel NLRP3 variants with CAPS phenotype in Turkish patients. Pediatric Rheumatology 2013.
11. Akdeniz S., Periyodik Ateş Sendromlarında TNFRSF1A geninin Öneminin Araştırılması [Yüksek Lisans Tezi] Akdeniz Üniversitesi; 2010

Toplam 11 adet kaynakça vardır.

Ayrıntılar

Birincil Dil	İngilizce
Konular	İmmünogenetik
Bölüm	Research Article
Yazarlar	Engin Altundağ 0000-0001-8841-1426 Ümmet Abur 0000-0002-4811-9321 Ömer Salih Akar 0000-0001-5686-2185 Alişan Yıldıran 0000-0002-2918-6238 Mehmet Halil Çeliksoy 0000-0002-4164-4668 Alberta G. A. Paul 0000-0002-9318-3760 Hatice Mutlu Albayrak 0000-0001-5624-3878 Medine Karadağ Alpaslan 0000-0002-9115-275X Gönül Oğur 0000-0002-9944-4423
Yayımlanma Tarihi	3 Ocak 2024
Gönderilme Tarihi	14 Ağustos 2023
Kabul Tarihi	10 Ekim 2023
Yayımlandığı Sayı	Yıl 2023 Cilt: 40 Sayı: 4

Kaynak Göster

APA	Altundağ, E., Abur, Ü., Akar, Ö. S., Yıldıran, A., vd. (2024). MVK, NLRP3, TNFRSF1A and MEFV gene mutation distributions in childhood autoinflammatory diseases: Experiences in North Anatolia. Journal of Experimental and Clinical Medicine, 40(4), 681-686.
AMA	Altundağ E, Abur Ü, Akar ÖS, Yıldıran A, Çeliksoy MH, Paul AGA, Mutlu Albayrak H, Karadağ Alpaslan M, Oğur G. MVK, NLRP3, TNFRSF1A and MEFV gene mutation distributions in childhood autoinflammatory diseases: Experiences in North Anatolia. J. Exp. Clin. Med. Ocak 2024;40(4):681-686.
Chicago	Altundağ, Engin, Ümmet Abur, Ömer Salih Akar, Alişan Yıldıran, Mehmet Halil Çeliksoy, Alberta G. A. Paul, Hatice Mutlu Albayrak, Medine Karadağ Alpaslan, ve Gönül Oğur. “MVK, NLRP3, TNFRSF1A and MEFV Gene Mutation Distributions in Childhood Autoinflammatory Diseases: Experiences in North Anatolia”. Journal of Experimental and Clinical Medicine 40, sy. 4 (Ocak 2024): 681-86.
EndNote	Altundağ E, Abur Ü, Akar ÖS, Yıldıran A, Çeliksoy MH, Paul AGA, Mutlu Albayrak H, Karadağ Alpaslan M, Oğur G (01 Ocak 2024) MVK, NLRP3, TNFRSF1A and MEFV gene mutation distributions in childhood autoinflammatory diseases: Experiences in North Anatolia. Journal of Experimental and Clinical Medicine 40 4 681–686.
IEEE	E. Altundağ, “MVK, NLRP3, TNFRSF1A and MEFV gene mutation distributions in childhood autoinflammatory diseases: Experiences in North Anatolia”, J. Exp. Clin. Med., c. 40, sy. 4, ss. 681–686, 2024.
ISNAD	Altundağ, Engin vd. “MVK, NLRP3, TNFRSF1A and MEFV Gene Mutation Distributions in Childhood Autoinflammatory Diseases: Experiences in North Anatolia”. Journal of Experimental and Clinical Medicine 40/4 (Ocak 2024), 681-686.
JAMA	Altundağ E, Abur Ü, Akar ÖS, Yıldıran A, Çeliksoy MH, Paul AGA, Mutlu Albayrak H, Karadağ Alpaslan M, Oğur G. MVK, NLRP3, TNFRSF1A and MEFV gene mutation distributions in childhood autoinflammatory diseases: Experiences in North Anatolia. J. Exp. Clin. Med. 2024;40:681–686.
MLA	Altundağ, Engin vd. “MVK, NLRP3, TNFRSF1A and MEFV Gene Mutation Distributions in Childhood Autoinflammatory Diseases: Experiences in North Anatolia”. Journal of Experimental and Clinical Medicine, c. 40, sy. 4, 2024, ss. 681-6.
Vancouver	Altundağ E, Abur Ü, Akar ÖS, Yıldıran A, Çeliksoy MH, Paul AGA, Mutlu Albayrak H, Karadağ Alpaslan M, Oğur G. MVK, NLRP3, TNFRSF1A and MEFV gene mutation distributions in childhood autoinflammatory diseases: Experiences in North Anatolia. J. Exp. Clin. Med. 2024;40(4):681-6.